Published on 5/25/2007 in the Prospect News PIPE Daily.
New Issue: Avalon Pharmaceuticals to raise $20 million from sale of shares
By Laura Lutz
Des Moines, May 25 - Avalon Pharmaceuticals, Inc. plans to conduct a private placement of shares for up to $20 million.
The company intends to sell up to 3,838,772 shares at $5.21 each. Investors will also receive warrants for at total of 959,693 shares. Each warrant will be exercisable at $6.00 for five years.
As of Friday morning, settlement was expected later in the day.
Avalon is a biopharmaceutical company based in Germantown, Md.
Issuer: | Avalon Pharmaceuticals, Inc.
|
Issue: | Shares
|
Amount: | $20 million
|
Shares: | 3,838,772
|
Price: | $5.21
|
Warrants: | For 959,693 shares
|
Warrant expiration: | Five years
|
Warrant strike price: | $6.00
|
Pricing date: | May 25
|
Settlement date: | May 25
|
Stock symbol: | Nasdaq: AVRX
|
Stock price: | $5.33 at close May 25
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.